CNTX (Context Therapeutics) FFO


CNTX Context Therapeutics Inc CNTX
30 GF Score
Price $0.58
! 1 Warning Sign
View Full Analysis

What is Context Therapeutics FFO?

FFO (Funds from operations) only applies to REITs.

CNTX
30GF Score
Context Therapeutics Inc CNTX
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Context Therapeutics Business Description

Other Exchanges 6K9:Germany
Address 2001 Market Street, Suite 3915, Unit No. 15, Philadelphia, PA, USA, 19103
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of various therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody (bsAb) that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.
30GF Score

Get the complete analysis for CNTX

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.58
Price